Eli Lilly And Co Company Profile

✉ Email this page to a colleague

ELI LILLY AND CO has seven approved drugs.

There are seventeen US patents protecting ELI LILLY AND CO drugs. There is one tentative approval on ELI LILLY AND CO drugs.

There are three hundred and forty-eight patent family members on ELI LILLY AND CO drugs in fifty-five countries and forty-four supplementary protection certificates in eighteen countries.

International Patents:	348
US Patents:	17
Tradenames:	9
Ingredients:	6
NDAs:	7
Drug Master File Entries:	37
Patent Litigation for Eli Lilly And Co:	See patent lawsuits for Eli Lilly And Co
PTAB Cases with Eli Lilly And Co as petitioner:	See PTAB cases with Eli Lilly And Co as petitioner
PTAB Cases with Eli Lilly And Co as patent owner:	See PTAB cases with Eli Lilly And Co as patent owner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-003	Jun 15, 1999	AB	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Eli Lilly And Co	SARAFEM	fluoxetine hydrochloride	CAPSULE;ORAL	018936-007	Jul 6, 2000		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Eli Lilly And Co	ZEPBOUND	tirzepatide	SOLUTION;SUBCUTANEOUS	217806-001	Nov 8, 2023		RX	Yes	Yes	11,357,820	⤷ Try a Trial	Y			⤷ Try a Trial
Eli Lilly And Co	MOUNJARO	tirzepatide	SOLUTION;SUBCUTANEOUS	215866-007	Jul 28, 2023		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Eli Lilly And Co	SARAFEM	fluoxetine hydrochloride	CAPSULE;ORAL	018936-007	Jul 6, 2000	5,114,976*PED	⤷ Try a Trial
Eli Lilly And Co	SARAFEM	fluoxetine hydrochloride	CAPSULE;ORAL	018936-007	Jul 6, 2000	4,971,998*PED	⤷ Try a Trial
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-001	Dec 29, 1987	4,194,009	⤷ Try a Trial
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-001	Dec 29, 1987	4,035,511	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Solution	30 mg/1.5 mL	➤ Subscribe	2013-01-29

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2288610	CA 2017 00032	Denmark	⤷ Try a Trial	PRODUCT NAME: BARICITINIB AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REG. NO/DATE: EU/1 /16/1170 20170215
2288610	122017000045	Germany	⤷ Try a Trial	PRODUCT NAME: BARICITINIB; REGISTRATION NO/DATE: EU/1/16/1170 20170213
2288610	PA2017023,C2288610	Lithuania	⤷ Try a Trial	PRODUCT NAME: BARICITINIBAS IR FARMACINIU POZIURIU PRIIMTINOS JO DRUSKOS; REGISTRATION NO/DATE: EU/1/16/1170 20170213
2379528	132019000000037	Italy	⤷ Try a Trial	PRODUCT NAME: ABEMACICLIB(VERZENIOS); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1307, 20181001
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.